Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients

被引：11
|
作者：
Salvini, Marco [1 ]
Damonte, Camilla [2 ]
Mortara, Lorenzo [3 ]
Maggi, Fabrizio [1 ,2 ]
Bruno, Antonino [3 ,4 ]
Pellegrini, Giacomo [1 ,5 ]
Mora, Barbara [1 ,2 ]
Brociner, Marco [1 ]
Ingrassia, Alessia [1 ]
Mattarucchi, Roberta [1 ]
Bianchi, Benedetta [1 ]
Sirocchi, Davide [1 ]
Agnoli, Stefania [1 ]
Rumi, Elisa [6 ,7 ]
Merli, Michele [1 ]
Fossati, Alessandro [1 ]
Bassi, Susanna [1 ]
Bombelli, Raffaella [3 ]
Gallazzi, Matteo [3 ]
Borsani, Oscar [7 ]
Baj, Andreina [1 ,2 ]
Franchi, Matteo [5 ,8 ]
Grossi, Paolo A. [1 ,2 ]
Passamonti, Francesco [1 ,2 ]
机构：
[1] ASST Sette Laghi, Osped Circolo, Varese, Italy
[2] Univ Insubria, Dept Med & Surg, Varese, Italy
[3] Univ Insubria, Dept Biotechnol & Life Sci, Lab Immunol & Gen Pathol, Varese, Italy
[4] IRCCS MultiMed, Milan, Italy
[5] Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, Milan, Italy
[6] Fdn IRCCS Policlin San Matteo, Hematol, Pavia, Italy
[7] Univ Pavia, Dept Mol Med, Pavia, Italy
[8] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Unit Biostat Epidemiol & Publ Hlth, Milan, Italy
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 08期
关键词：
D O I：
10.1002/ajh.26629
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E321 / E324
页数：4
相关论文
共 50 条
  • [31] Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: a prospective cohort study
    Puspitasari, Metalia
    Sattwika, Prenali D. D.
    Rahari, Dzerlina S. S.
    Wijaya, Wynne
    Hidayat, Auliana R. P.
    Kertia, Nyoman
    Purwanto, Bambang
    Thobari, Jarir At
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [32] Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: a prospective cohort study
    Metalia Puspitasari
    Prenali D. Sattwika
    Dzerlina S. Rahari
    Wynne Wijaya
    Auliana R. P. Hidayat
    Nyoman Kertia
    Bambang Purwanto
    Jarir At Thobari
    Scientific Reports, 13
  • [33] Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
    Geisen, Ulf M.
    Berner, Dennis K.
    Tran, Florian
    Suembuel, Melike
    Vullriede, Lena
    Ciripoi, Maria
    Reid, Hayley M.
    Schaffarzyk, Annika
    Longardt, Ann C.
    Franzenburg, Jeanette
    Hoff, Paula
    Schirmer, Jan H.
    Zeuner, Rainald
    Friedrichs, Anette
    Steinbach, Andrea
    Knies, Christine
    Markewitz, Robert D. H.
    Morrison, Peter J.
    Gerdes, Sascha
    Schreiber, Stefan
    Hoyer, Bimba F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (10) : 1306 - 1311
  • [34] THE IMPACT OF ANTI-SARS-COV-2 VACCINES IN A MULTICENTER COHORT STUDY OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Gerosa, M.
    Schioppo, T.
    Argolini, L. M.
    Sciascia, S.
    Ramirez, G. A.
    Moroni, G.
    Sinico, R. A.
    Alberici, F.
    Moroni, L.
    Tamborini, F.
    Miraglia, P.
    Bellocchi, C.
    Beretta, L.
    Roccatello, D.
    Dagna, L.
    Bozzolo, E.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 951 - 952
  • [35] The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study
    Gerosa, Maria
    Schioppo, Tommaso
    Argolini, Lorenza Maria
    Sciascia, Savino
    Ramirez, Giuseppe Alvise
    Moroni, Gabriella
    Sinico, Renato Alberto
    Bonelli, Grazia
    Alberici, Federico
    Mescia, Federica
    Moroni, Luca
    Tamborini, Francesco
    Miraglia, Paolo
    Bellocchi, Chiara
    Beretta, Lorenzo
    Roccatello, Dario
    Dagna, Lorenzo
    Bozzolo, Enrica
    Caporali, Roberto
    VACCINES, 2022, 10 (05)
  • [36] It is time to adapt anti-CD20 administration schedules to allow efficient anti-SARS-CoV-2 vaccination in patients with lymphoid malignancies
    Besson, Caroline
    HAEMATOLOGICA, 2022, 107 (03) : 572 - 573
  • [37] Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination-A Retrospective Cohort Study
    Wirth, Stella Rosa Maria
    Podar, Klaus
    Pecherstorfer, Martin
    Wohlfarth, Philipp
    Jaeger, Ulrich
    Singer, Josef
    CANCERS, 2023, 15 (02)
  • [38] Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study
    Lasagna, A.
    Bergami, F.
    Lilleri, D.
    Percivalle, E.
    Quaccini, M.
    Alessio, N.
    Comolli, G.
    Sarasini, A.
    Sammartino, J. C.
    Ferrari, A.
    Arena, F.
    Secondino, S.
    Cicognini, D.
    Schiavo, R.
    Lo Cascio, G.
    Cavanna, L.
    Baldanti, F.
    Pedrazzoli, P.
    Cassaniti, I
    ESMO OPEN, 2022, 7 (02)
  • [39] Immunogenicity of vaccination against SARS-COV-2 in heart transplant patients. Prospective study in Galicia
    Generosa Crespo-Leiro, M. Maria
    Bou-Arevalo, G.
    Rodriguez-Vazquez, P.
    Blanco-Canosa, P.
    Grille-Cancela, Z.
    Naya-Leira, C.
    Riveiro-Rodriguez, C.
    Paniagua-Martin, M. J.
    Barge-Caballero, G.
    Couto-Mallon, D.
    Lopez-Vazquez, P.
    Domenech-Garcia, N.
    Sagastagoitia-Fornie, M.
    Henriquez-Vazquez, D.
    Barge-Caballero, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 137 - 138
  • [40] Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients
    Cona, Maria Silvia
    Riva, Agostino
    Dalu, Davide
    Gabrieli, Arianna
    Fasola, Cinzia
    Lipari, Giuseppe
    Pozza, Giacomo
    Rulli, Eliana
    Galli, Francesca
    Ruggieri, Lorenzo
    Masedu, Elsa
    Parma, Gaia
    Chizzoniti, Davide
    Gambaro, Anna
    Ferrario, Sabrina
    Antista, Maria
    De Monte, Matteo
    Tarkowski, Maciej S.
    La Verde, Nicla
    CANCER MEDICINE, 2023, 12 (12): : 12967 - 12974
12345